Form 4 for ABBV AbbVie
Accepted 2023-04-05 00:00:00 ET · period of report 2023-04-03 · accession 0001415889-23-006300 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-05 | 2023-04-03 | ABBV | Siatis Perry C | EVP, GC AND Sec | S - Sale+OE | $160.00 | -3,520 | 10.4K | -25% | -$563.2K |
| D | 2023-04-05 | 2023-04-03 | ABBV | Siatis Perry C | EVP, GC AND Sec | M - OptEx | $105.92 | +3,520 | 13.9K | +34% | +$372.8K |
| D | 2023-04-05 | 2023-04-03 | ABBV | Siatis Perry C | EVP, GC AND Sec | M - OptEx | $105.92 | -3,520 | 3,520 | -50% | -$372.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2023-04-03 | S | D | 3,520 | $160.00 | 10,377 | D | — | — | |
| 2 | Common | Common Stock, $0.01 par value | 2023-04-03 | M | A | 3,520 | $105.92 | 13,897 | D | — | — | |
| 3 | Derivative | Option (Right to buy) | 2023-04-03 | M | D | 3,520 | $105.92 | 3,520 | D | $105.92 · 2022-02-18 to 2031-02-17 | 3,520 Common Stock | (F1) Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |